期刊文献+

氨氯地平联合比索洛尔治疗肾性高血压23例 被引量:3

Amlodipine Combined with Bisoprolol for the Treatment of Renal Hypertension
下载PDF
导出
摘要 目的观察氨氯地平联合比索洛尔治疗肾性高血压的疗效和安全性。方法将51例肾性高血压患者随机分为两组。对照组28例给予氨氯地平5.0mg,po,q12h;治疗组23例给予氨氯地平2.5~5.0mg,po,qd,同时给予比索洛尔2.5~5.0mg,po,qd。两组均连用8周。监测治疗前后血压、心率、肾功能等。结果对照组降血压总有效率67.9%,治疗组总有效率82.6%。两组患者治疗前后心率、肾功能等均无明显改变,无明显不良反应。结论氨氯地平联合比索洛尔治疗肾性高血压安全有效,其疗效优于单用氨氯地平。 Objective To evaluate the effects and safety of amlodipine combined with bisoprololin for the treatment of renal hypertension. Methods Fifty-one patients with renal hypertension were randomly divided into two groups. 28 Patients in the control group were treated with amlodipine 5.0 mg q12 h,while 23 in the treatment group were treated with amlodipine 5 mg qd and bisoprolol 2.5 - 5.0 mg qd for eight weeks. Blood pressure, heart rate and renal function were monitored before and after treatment. Results The total antihypertensive effective rates were 67.9% and 82.6% in the control and treatment group, respectively. There were no significant changes in heart rate and renal function before and after treatment in both groups and no obvious adverse events occurred. Conclusion Amlodipine combined with bisoprolol was efficient and safe for the treatment of renal hypertension, and was more effective than amlodipine used alone.
出处 《医药导报》 CAS 2009年第11期1456-1458,共3页 Herald of Medicine
关键词 氨氯地平 比索洛尔 高血压 肾性 Amlodipine Bisoprolul Hypertension, renal
  • 相关文献

参考文献2

二级参考文献15

  • 1中国高血压防治指南修订委员会.中国高血压防治指南(2005年修订版)[M].北京:人民卫生出版社,2005.
  • 2CHOBANIAN A V,BAKRIS G L,BLACK H R,et al.The seventh report of the joint national committee on prevention,detection,evaluation and treatment of high blood pressure:the JNC-7 report[J].JAMA,2003,289(22):2560-2572.
  • 3Guidelines Committee.2003 European Society of Hypertension European Society of Cardiology guidelines for the management of arterial hypertension[J].J Hypertens,2003,21:1021-1053.
  • 4ANON.Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)[J].JAMA,2002,288(23):2981 -2997.
  • 5JOUNELA A J,LILJA M,LUMMEJ,et al.Relation between low dose of hydrochlorothiazide,antihypertensive effect and adverse effects[J].Blood Press,1994,3:231-235.
  • 6POOLE-WILSON PA,LABSEN J,KIRWAN B A,et al.Effect of long acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial):randomized controlled trial[J].Lancet,2004,364 (9437):849 -857.
  • 7WING L M,REID C M,RYAN P,et al.A comparison of outcomes with angiotensin converting enzyme inhibitors and diuretics for hypertension in the elderly[J].N Engl J Med,2003,348(7):583 -592.
  • 8JULIUS S,KJELDSEN S E,WEBER M,et al.Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine:the VALUE randomised trial[J].Lancet,2004,363:2022 -2031.
  • 9KOSTIS J B,PACKER M,BLACK H R,et al.Omapatrilat and enalapril in patients with hypertension:the Omapatrilat Cardiovascular Treatment vs.Enalapril (OCTAVE) trial[J].Am J Hypertens,2004,17 (2):103-111.
  • 10WILLIAMS G H,BURGESS E,KOLLOCH R E,et al.Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension[J].Am J Cardiol,2004,93 (8):990-996.

共引文献61

同被引文献15

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部